Cargando…

Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction

Heart failure with reduced ejection fraction (HFrEF) constitutes 50% of HF hospitalizations and is characterized by high rates of mortality. To explore the underlying mechanisms of HFrEF etiology and progression, we studied the molecular and cellular differences in four chambers of non-failing (NF,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xin, Yin, Jun, Dwyer, Denise, Yamawaki, Tracy, Zhou, Hong, Ge, Hongfei, Han, Chun-Ya, Shkumatov, Artem, Snyder, Karen, Ason, Brandon, Li, Chi-Ming, Homann, Oliver, Stolina, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178406/ https://www.ncbi.nlm.nih.gov/pubmed/34088950 http://dx.doi.org/10.1038/s41598-021-91214-2

Ejemplares similares

The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
por: Stolina, Marina, et al.
Publicado: (2020)

Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death in mice
por: Ge, Hongfei, et al.
Publicado: (2021)

Stigmasterol accumulation causes cardiac injury and promotes mortality
por: Tao, Caroline, et al.
Publicado: (2019)

Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts
por: Shi, Sally Yu, et al.
Publicado: (2021)

Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction
por: Hasselberg, Nina E., et al.
Publicado: (2015)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
por: Ovchinnikov, Artem, et al.
Publicado: (2022)

Secondary emission chambers in the ejected beams of the cps
por: Agoritsas, V
Publicado: (1970)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques
por: Tombolesi, Niki, et al.
Publicado: (2022)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)

Secondary Emission Chambers for Monitoring the CPS Ejected Beams
por: Agoritsas, V
Publicado: (1968)

Trajectories and vacuum chambers for ejection from ss 16
por: Richter, W
Publicado: (1968)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Matrix Rigidity-Modulated Cardiovascular Organoid Formation from Embryoid Bodies
por: Shkumatov, Artem, et al.
Publicado: (2014)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
por: Chen, Xiao-Xiang, et al.
Publicado: (2013)

Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction
por: Barbieri, Andrea, et al.
Publicado: (2023)

Outcome of cardiac surgery in patients with low preoperative ejection fraction
por: Pieri, Marina, et al.
Publicado: (2016)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Prognostic Implications of Changes in Left Ventricular Ejection Fraction and Pulmonary Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
por: Kim, Hyun-Jin
Publicado: (2019)

Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction
por: Kewcharoen, Jakrin, et al.
Publicado: (2022)

Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism
por: Yu, Longchuan, et al.
Publicado: (2017)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Hyperdynamic ejection fraction in the critically ill patient
por: Paonessa, JR, et al.
Publicado: (2014)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

T1 mapping across the ejection fraction spectrum
por: Alaour, Bashir, et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lbj2bkjihaeu3nj4fntmhbe7sq